HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS:HQY) from Outperform ...

HealthEquity, Inc.’s HQY share price has dipped by 17.07%, which has investors questioning if this is right time to buy.

Raymond James upgraded HealthEquity (HQY) to Strong Buy from Outperform with a price target of $115, down from $120. The firm upgrade the ...

HealthEquity (NASDAQ:HQY – Get Free Report) was upgraded by analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Tuesday, MarketBeat.com ...

HealthEquity stock drops after mixed Q4 results despite 18.8% revenue growth. Click here to find out why HQY stock is a Hold.

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (BMV ... VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,744K shares ...